Literature DB >> 18092011

Acinetobacter pneumonia: a review.

Joshua D Hartzell1, Andrew S Kim, Mark G Kortepeter, Kimberly A Moran.   

Abstract

Acinetobacter species are becoming a major cause of nosocomial infections, including hospital-acquired and ventilator-associated pneumonia. Acinetobacter species have become increasingly resistant to antibiotics over the past several years and currently present a significant challenge in treating these infections. Physicians now rely on older agents, such as polymyxins (colistin), for treatment. This paper reviews the epidemiology, treatment, and prevention of this emerging pathogen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18092011      PMCID: PMC2100077     

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


  98 in total

1.  Computer keyboards as reservoirs for Acinetobacter baumannii in a burn hospital.

Authors:  A N Neely; M P Maley; G D Warden
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

2.  [CLINICAL OBSERVATIONS ON THE ACTIVITY OF AEROSOL COLIMYCIN AND OF ENDOBRONCHIAL INSTILLATIONS OF COLIMYCIN IN PATIENTS WITH PULMONARY SUPPURATIONS].

Authors:  G PINO; G CONTERNO; P G COLONGO
Journal:  Minerva Med       Date:  1963-07-21       Impact factor: 4.806

3.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

4.  Use of colistin in the treatment of multiple-drug-resistant gram-negative infections.

Authors:  David Berlana; J M Llop; E Fort; M B Badia; R Jódar
Journal:  Am J Health Syst Pharm       Date:  2005-01-01       Impact factor: 2.637

5.  Fulminant community-acquired Acinetobacter pneumonia in a healthy woman.

Authors:  J A Bick; J D Semel
Journal:  Clin Infect Dis       Date:  1993-10       Impact factor: 9.079

6.  Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices.

Authors:  J Rello; M Sa-Borges; H Correa; S R Leal; J Baraibar
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

7.  Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals.

Authors:  Jesús Rodríguez-Baño; Jose M Cisneros; Felipe Fernández-Cuenca; Anna Ribera; Jordi Vila; Alvaro Pascual; Luis Martínez-Martínez; German Bou; Jerónimo Pachón
Journal:  Infect Control Hosp Epidemiol       Date:  2004-10       Impact factor: 3.254

8.  Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.

Authors:  Abelardo Montero; Javier Ariza; Xavier Corbella; Alejandro Doménech; Carmen Cabellos; Josefina Ayats; Fe Tubau; Carmen Borraz; Francesc Gudiol
Journal:  J Antimicrob Chemother       Date:  2004-11-16       Impact factor: 5.790

9.  Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-11-19       Impact factor: 17.586

10.  Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.

Authors:  Argyris Michalopoulos; Sofia K Kasiakou; Zefi Mastora; Kostas Rellos; Anastasios M Kapaskelis; Matthew E Falagas
Journal:  Crit Care       Date:  2005-01-06       Impact factor: 9.097

View more
  19 in total

1.  Current advances and challenges in the development of Acinetobacter vaccines.

Authors:  Wangxue Chen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Human fluids alter DNA-acquisition in Acinetobacter baumannii.

Authors:  Jasmine Martinez; Christine Liu; Nyah Rodman; Jennifer S Fernandez; Claudia Barberis; Rodrigo Sieira; Federico Perez; Robert A Bonomo; Maria Soledad Ramirez
Journal:  Diagn Microbiol Infect Dis       Date:  2018-10-23       Impact factor: 2.803

3.  Droperidol as a potential inhibitor of acyl-homoserine lactone synthase from A. baumannii: insights from virtual screening, MD simulations and MM/PBSA calculations.

Authors:  Rajat Kumar Jha; Ekampreet Singh; Rameez Jabeer Khan; Ankit Kumar; Monika Jain; Jayaraman Muthukumaran; Amit Kumar Singh
Journal:  Mol Divers       Date:  2022-10-03       Impact factor: 3.364

4.  Acinetobacter pneumonia: Is the outcome different from the pneumonias caused by other agents.

Authors:  Ebru Cakir Edis; Osman N Hatipoglu; Ozlem Tansel; Necdet Sut
Journal:  Ann Thorac Med       Date:  2010-04       Impact factor: 2.219

5.  Multidrug resistant acinetobacter.

Authors:  Vikas Manchanda; Sinha Sanchaita; Np Singh
Journal:  J Glob Infect Dis       Date:  2010-09

6.  A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain.

Authors:  Greg Harris; Rhonda Kuo Lee; Christopher K Lam; Gregory Kanzaki; Girishchandra B Patel; H Howard Xu; Wangxue Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

7.  Case fatality rate related to nosocomial and ventilator-associated pneumonia in an ICU: a single-centre retrospective cohort study.

Authors:  Murat Yalçınsoy; Cuneyt Salturk; Hurıye Berk Takır; Semra Batı Kutlu; Ayşegul Oguz; Emine Aksoy; Merih Balcı; Feyza Kargın; Ozlem Yazıcıoglu Mocin; Nalan Adıguzel; Gokay Gungor; Zuhal Karakurt
Journal:  Wien Klin Wochenschr       Date:  2015-11-05       Impact factor: 1.704

8.  Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit.

Authors:  Ji Ye Jung; Moo Suk Park; Song Ee Kim; Byung Hoon Park; Ji Young Son; Eun Young Kim; Joo Eun Lim; Sang Kook Lee; Sang Hoon Lee; Kyung Jong Lee; Young Ae Kang; Se Kyu Kim; Joon Chang; Young Sam Kim
Journal:  BMC Infect Dis       Date:  2010-07-30       Impact factor: 3.090

9.  Multiple lung abscesses due to acinetobacter infection: a case report.

Authors:  Ioannis Kokkonouzis; Ioannis Christou; Ioannis Athanasopoulos; Nikolaos Saridis; Vasilios Skoufaras
Journal:  Cases J       Date:  2009-12-18

10.  Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis.

Authors:  Mehrdad Behnia; Sharon C Logan; Linda Fallen; Philip Catalano
Journal:  BMC Res Notes       Date:  2014-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.